GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Prostate Cancer Prevention and Treatment by Silibinin

$322,493
Rajesh Agarwal · University Of Colorado Denver · R01 · FY2012 · CA

Engineering tissue inhibitor of metalloproteinases-2 (TIMP-2) for triple negative breast cancer therapy

$322,492
Evette S Radisky · Mayo Clinic Jacksonville · R01 · FY2025 · CA

Cytokine- and Satellite Cell-mediated Muscle Disease Promotion

$322,447
Charles Keller · Children'S Cancer Therapy Develop/Inst · R01 · FY2016 · CA

Anti-tumor Immunity in Myeloma

$322,425
Madhav V Dhodapkar · Yale University · R01 · FY2012 · CA

Definition of Microenvironment in Breast Cancer

$322,420
Mina J Bissell · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2007 · CA

The role of ERRalpha/PGC-1 in disease pathogenesis

$322,347
Donald P McDonnell · Duke University · R01 · FY2013 · CA

Stromal Fibroblast Autophagy In Tumor Progression and Desmoplasia

$322,310
Jayanta Debnath · University Of California, San Francisco · R01 · FY2022 · CA

Core 2: Analytical Core

$322,245
Nathalie Yr Agar · Massachusetts Institute Of Technology · U54 · FY2025 · CA

Kallikrein-Targeted Alpha-Particle Therapy of Late-Stage Prostate Cancer

$322,244
Daniel Lyndon Jaffe Thorek · Washington University · R01 · FY2020 · CA

A Phase I Open Label, Dose Escalation Clinical Trial Assessing the Safety, Tolerability, and Feasibility of pNGVL4aCRTE6E7L2 HPV DNA Vaccine Administration Via Intramuscular TriGridTM Electroporation

$322,209
Richard Bruce Roden · Johns Hopkins University · P50 · FY2024 · CA

Role of the collagen receptor LAIR-1 in glioma progression and the tumor immune microenvironment

$322,181
Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2025 · NS

Role of IL10 and TGFb1 in colon cancer

$322,150
Susan E. Erdman · Massachusetts Institute Of Technology · R01 · FY2011 · CA

IMPACT OF THE MICROENVIRONMENT ON THERAPEUTIC RESPONSE

$322,144
Mary Helen Barcellos-Hoff · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2008 · CA

Differential metabolic network analysis of tumor progression

$322,096
James P Freyer · University Of New Mexico · R01 · FY2010 · CA

Synergy of radiation and immunotherapy: new approaches

$322,083
Yang-Xin Fu · University Of Chicago · R01 · FY2014 · CA

Development of novel metastatic mouse models that recapitulate the major immune contexts of human colon cancer

$322,064
Tyler E Jacks · Massachusetts Institute Of Technology · R01 · FY2022 · CA

Automated Classification of Pediatric Soft Tissue Sarcoma from Histopathology Images

$322,063
Anna Karolina Palucka · Jackson Laboratory · P30 · FY2023 · CA

Local Radiation as an Adjuvant for Immunotherapy

$322,050
Sandra Demaria · New York University School Of Medicine · R01 · FY2009 · CA

Local Radiation as an Adjuvant for Immunotherapy

$322,050
Sandra Demaria · New York University School Of Medicine · R01 · FY2010 · CA

Autocrine Wnt signaling in human breast and ovarian cancer cells

$322,050
Anna Bafico · Icahn School Of Medicine At Mount Sinai · R01 · FY2008 · CA

Autocrine Wnt signaling in human breast and ovarian cancer cells

$322,050
Anna Bafico · Icahn School Of Medicine At Mount Sinai · R01 · FY2007 · CA

Local Radiation as an Adjuvant for Immunotherapy

$322,050
Sandra Demaria · New York University School Of Medicine · R01 · FY2008 · CA

Tumor antigen-specific T-cells and hepatocellular carcinoma

$322,040
David E Kaplan · University Of Pennsylvania · R01 · FY2014 · CA

DCE-MRI for Assessment of Vascular Normalization by Nelfinavir in Lung Cancer

$322,040
Ramesh Rengan · University Of Pennsylvania · R21 · FY2011 · CA

Role of SNF1 Kinase HUNK in breast cancer progression

$322,040
Lewis A Chodosh · University Of Pennsylvania · R01 · FY2012 · CA